Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical ...

or the database it comes from, said Martina Markova, a senior product manager at Graphwise, a company that builds knowledge graphs for businesses. The Oxford Drug Discovery Institute’s ...